Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients.

Br J Cancer · 2009 · PMC2661774 · PMID 19240719

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

did not reach statistical significanceP =0.086so close (0.05 < p ≤ 0.1)

Trastuzumab treatment after BM also showed a high HR, though it did not reach statistical significance ( P =0.086, HR 3.597).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.